Skip to content
Abierto

Solicitation, first published as presolicitation

Request for Proposals - Phase I Clinical Trials

75N95024R00086

National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

Response deadline

October 11, 2024 at 5:00 PM EDT

Closed 708 days ago. Posted September 27, 2024, first published July 16, 2024. Scheduled to archive October 26, 2024.

Description

As published on SAM.gov.

Amendment 0003: The attached amendment provides responses to additional vendor-submitted questions.

Amendment 0002: The attached amendment provides responses to vendor-submitted questions; revises the RFP document and RFP Attachments 9 and 10 (Sample Task Order #2 and #3 SOWs); and extends the response deadline to 10/11/2024 at 5 pm ET. Phase I Clinical Trials for Development of Small Molecule and Biologics Therapeutics

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 16, 2024

    Presolicitation

    Phase I Clinical Trials for Development of Neurotherapeutics

    Due July 31, 2024 at 5:00 PM EDT. SAM.gov, notice 3276ea1f9dff4dba848c511ee92789ec

  2. July 29, 2024

    Presolicitation

    Phase I Clinical Trials for Development of Neurotherapeutics

    Due August 7, 2024 at 5:00 PM EDT. SAM.gov, notice e6a278785c614df6b16b62f8935d22ab

  3. August 7, 2024

    Presolicitation

    Phase I Clinical Trials for Development of Neurotherapeutics

    Due August 14, 2024 at 5:00 PM EDT. SAM.gov, notice 727d5942c2ca47d1981f8d8a846fdcad

  4. August 15, 2024

    Presolicitation

    Phase I Clinical Trials for Development of Neurotherapeutics

    Due August 16, 2024 at 3:00 PM EDT. SAM.gov, notice 9f04e2a8619a430b8f175c14e4838936

  5. August 16, 2024

    Presolicitation

    Phase I Clinical Trials for Development of Neurotherapeutics

    Due August 19, 2024 at 3:00 PM EDT. SAM.gov, notice 7574eb2e1d804fb3954178c8705e11d5

  6. August 19, 2024

    Solicitation, originally presolicitation

    Phase I Clinical Trials for Development of Small M

    Due October 3, 2024 at 5:00 PM EDT. SAM.gov, notice 05a5b5c950b04be991dcb7f1377e26ad

  7. August 19, 2024

    Solicitation

    Due October 3, 2024 at 5:00 PM EDT. SAM.gov, notice bb3cab7344484e8fa08b2cf7be2f8c5e

  8. September 20, 2024

    Solicitation

    Due October 11, 2024 at 5:00 PM EDT. SAM.gov, notice 1a0147b64ca342acb019b9f8f9292bba

  9. September 27, 2024

    Solicitation

    Due October 11, 2024 at 5:00 PM EDT. SAM.gov, notice 485a862440f04e328cd76e95ac516503

Points of contact